Amir Razaghizad

10PUBLICATIONS
32CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyRespiratory diseasesVideo processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 20, 2024
Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the CANVAS Program and CREDENCE trial.

Amir Razaghizad, Jiayi Ni, Pedro Marques

|Jan 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial.

Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury

|Nov 23, 2023
Authorship Correction: Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial.

Emily Oulousian, Seok Hoon Chung, Elie Ganni

|Aug 11, 2023
Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF.

Abhinav Sharma, Daniel Caldeira, Amir Razaghizad

|Jan 31, 2023
Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial.

Emily Oulousian, Seok Hoon Chung, Elie Ganni

|Sep 09, 2022
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial.

Amir Razaghizad, Abhinav Sharma, Jiayi Ni

Pageof 2

Frequent Collaborators

9 joint publications

Abhinav Sharma

3 joint publications

João Pedro Ferreira

2 joint publications

Pedro Marques

2 joint publications

Guang Zhang